Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;78(6):1750-1759.
doi: 10.1161/HYPERTENSIONAHA.121.17875. Epub 2021 Nov 1.

Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

Affiliations

Locomotor Muscle Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

Michael A Francisco et al. Hypertension. 2021 Dec.

Abstract

[Figure: see text].

Keywords: biomarkers; heart failure; hyperemia; inflammation; muscles.

PubMed Disclaimer

Conflict of interest statement

Disclosures

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

FIGURE 1:
FIGURE 1:
Panel A: Changes in leg blood flow during 1 minute of passive leg movement in controls and patients with HFpEF. Area under the curve (AUC) was calculated as the summed second-by-second values during passive movement. Panel B: Peak change in leg blood flow achieved during 1 minute of passive leg movement in controls and patients with HFpEF. *Significantly different than control, P < 0.05. HFpEF n = 43; Control n = 39. Data are mean ± SEM
FIGURE 2:
FIGURE 2:
Panel A: Changes in leg vascular conductance during 1 minute of passive leg movement in controls and patients with HFpEF. Area under the curve (AUC) was calculated as the summed second-by-second values during passive movement. Panel B: Peak change in leg vascular conductance achieved during 1 minute of passive leg movement in controls and patients with HFpEF. *Significantly different than control, P < 0.05. HFpEF n = 40; Control n = 35. Data are mean ± SEM
FIGURE 3:
FIGURE 3:
Serum biomarkers of inflammation, as assessed by C-reactive protein (panel A), Tumor Nercrosis Factor-α (panel B), and Interleukin-6 (panel C) in controls and patients with HFpEF. * Significantly different than control, P < 0.05. HFpEF n = 27; Control n = 35. Data are mean ± SEM
FIGURE 4:
FIGURE 4:
Serum biomarkers of oxidative damage, as assessed by protein carbonyl (panel A, HFpEF n = 26; Control n = 33) and malondialdehyde (panel B, HFpEF n = 27; Control n = 35) in controls and patients with HFpEF. * Significantly different than control, P < 0.05. Data are mean ± SEM

References

    1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation 2011; 123:933–944. - PubMed
    1. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355:260–269. - PubMed
    1. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. J Am Med Assoc 2006; 296:2209–2216. - PubMed
    1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med 2006; 355:251–259. - PubMed
    1. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Gregory Hundley W, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. J Am Med Assoc 2002; 288:2144–2150. - PubMed

Publication types